Apellis Pharmaceuticals, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
144/A
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POSASR
RW
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001950047-25-001580 | Mar 5, 2025 | — |
| S-8 | S-8 | 0001193125-25-040673 | Feb 28, 2025 | — |
| 10-K | 10-K | 0000950170-25-029507 | Feb 28, 2025 | Dec 31, 2024 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-004328 | Feb 12, 2025 | Feb 11, 2025 |
| 144 | — | 0001959173-25-000878 | Feb 11, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000121 | Feb 10, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001127602-25-002379 | Jan 30, 2025 | Jan 29, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-002375 | Jan 30, 2025 | Jan 29, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-002387 | Jan 30, 2025 | Jan 29, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-002373 | Jan 30, 2025 | Jan 29, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-002389 | Jan 30, 2025 | Jan 29, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-002381 | Jan 30, 2025 | Jan 29, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-002383 | Jan 30, 2025 | Jan 29, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-002385 | Jan 30, 2025 | Jan 29, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-002377 | Jan 30, 2025 | Jan 29, 2025 |
| 144 | — | 0001959173-25-000531 | Jan 29, 2025 | — |
| 144 | — | 0001959173-25-000526 | Jan 29, 2025 | — |
| 144 | — | 0001959173-25-000532 | Jan 29, 2025 | — |
| 144 | — | 0001959173-25-000527 | Jan 29, 2025 | — |
| 144 | — | 0001959173-25-000528 | Jan 29, 2025 | — |
| 144 | — | 0001959173-25-000529 | Jan 29, 2025 | — |
| 144 | — | 0001959173-25-000533 | Jan 29, 2025 | — |
| 144 | — | 0001959173-25-000534 | Jan 29, 2025 | — |
| 144 | — | 0001959173-25-000530 | Jan 29, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001843 | Jan 23, 2025 | Jan 22, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001845 | Jan 23, 2025 | Jan 22, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001847 | Jan 23, 2025 | Jan 22, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001829 | Jan 23, 2025 | Jan 22, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001833 | Jan 23, 2025 | Jan 22, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001831 | Jan 23, 2025 | Jan 22, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001839 | Jan 23, 2025 | Jan 22, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001835 | Jan 23, 2025 | Jan 22, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001837 | Jan 23, 2025 | Jan 22, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001841 | Jan 23, 2025 | Jan 22, 2025 |
| 144 | — | 0001959173-25-000428 | Jan 22, 2025 | — |
| 144 | — | 0001959173-25-000419 | Jan 22, 2025 | — |
| 144 | — | 0001959173-25-000420 | Jan 22, 2025 | — |
| 144 | — | 0001959173-25-000421 | Jan 22, 2025 | — |
| 144 | — | 0001959173-25-000422 | Jan 22, 2025 | — |
| 144 | — | 0001959173-25-000423 | Jan 22, 2025 | — |
| 144 | — | 0001959173-25-000424 | Jan 22, 2025 | — |
| 144 | — | 0001959173-25-000425 | Jan 22, 2025 | — |
| 144 | — | 0001959173-25-000426 | Jan 22, 2025 | — |
| 144 | — | 0001959173-25-000427 | Jan 22, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001616 | Jan 21, 2025 | Jan 17, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001618 | Jan 21, 2025 | Jan 17, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001620 | Jan 21, 2025 | Jan 17, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001623 | Jan 21, 2025 | Jan 17, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001625 | Jan 21, 2025 | Jan 17, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-001627 | Jan 21, 2025 | Jan 17, 2025 |